Checklist for annual updates for parallel distribution: guidance for industry
Submitted by Anonymous (not verified) on 6 January 2025 - 8:16
Checklist for annual updates for parallel distribution: guidance for industry
Checklist for initial notifications for parallel distribution: guidance for industry
Submitted by Anonymous (not verified) on 6 January 2025 - 8:15
Checklist for initial notifications for parallel distribution: guidance for industry
Certification of medicinal products
Submitted by Anonymous (not verified) on 6 January 2025 - 7:56
Certification of medicinal products
Information package for certificates of medicinal products issued by the European Medicines Agency
Submitted by Anonymous (not verified) on 6 January 2025 - 7:54
Information package for certificates of medicinal products issued by the European Medicines Agency
EFIM Exchange programme - deadline ended!
Submitted by Aneta on 20 December 2024 - 14:24
EFIM Exchange programme is closed for 2025! The Selection of received application is in process.
No more application will be accepted!
We are delighted to announce that applications for the EFIM Exchange Programme 2025 are now open!
Veterinary medicines European public assessment report (EPAR): Nobivac L4, Vaccine to prevent Leptospira infections in dogs, Status: Authorised
Submitted by Anonymous (not verified) on 19 December 2024 - 13:30
Veterinary medicines European public assessment report (EPAR): Nobivac L4, Vaccine to prevent Leptospira infections in dogs, Status: Authorised
Veterinary medicines European public assessment report (EPAR): Versican Plus DHPPi, canine distemper virus, canine adenovirus, canine parvovirus, canine parainfluenza virus, Status: Authorised
Submitted by Anonymous (not verified) on 19 December 2024 - 13:30
Veterinary medicines European public assessment report (EPAR): Versican Plus DHPPi, canine distemper virus, canine adenovirus, canine parvovirus, canine parainfluenza virus, Status: Authorised
Veterinary medicines European public assessment report (EPAR): Versican Plus DHPPi/L4, live, attenuated Canine distemper virus, canine adenovirus, canine parvovirus, canine parainfluenza virus inactivated, Status: Authorised
Submitted by Anonymous (not verified) on 19 December 2024 - 13:30
Veterinary medicines European public assessment report (EPAR): Versican Plus DHPPi/L4, live, attenuated Canine distemper virus, canine adenovirus, canine parvovirus, canine parainfluenza virus inactivated, Status: Authorised
Trametinib product-specific bioequivalence guideline
Submitted by Anonymous (not verified) on 19 December 2024 - 12:48
Trametinib product-specific bioequivalence guideline
Human medicines European public assessment report (EPAR): Idelvion, albutrepenonacog alfa, Date of authorisation: 11/05/2016, Revision: 13, Status: Authorised
Submitted by Anonymous (not verified) on 19 December 2024 - 11:27
Human medicines European public assessment report (EPAR): Idelvion, albutrepenonacog alfa, Date of authorisation: 11/05/2016, Revision: 13, Status: Authorised